Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemia

There is a need to define the therapeutic strategy in older patients with acute myeloid leukemia. This study suggests that cytogenetics is of fundamental importance in decision making: patients with unfavorable cytogenetics should not be considered for standard induction chemotherapy. See related pe... View More